XNK Therapeutics appoints Markus Thor as Chief Business Officer
Sept. 3, 2021 XNK Therapeutics AB (“XNK”) today announced the appointment of Markus Thor as Chief Business Officer, effective September 6[th]. He will be member of the company’s management team. Mr. Thor is an experienced business development executive with 25 years’ experience from the life science industry. In previous roles he was responsible for structuring, negotiating and closing a range of global, strategic business agreements, including in- and out-licensing, acquisitions and R&D collaborations. Prior to joining XNK, Mr. Thor worked more than a decade at Biovitrum AB,